Literature DB >> 30480376

Characterization and regulation of MT1-MMP cell surface-associated activity.

Sonia Pahwa1, Manishabrata Bhowmick1, Sabrina Amar1,2, Jian Cao3, Alex Y Strongin4, Rafael Fridman5, Stephen J Weiss6, Gregg B Fields1,2,7.   

Abstract

Quantitative assessment of MT1-MMP cell surface-associated proteolytic activity remains undefined. Presently, MT1-MMP was stably expressed and a cell-based FRET assay developed to quantify activity toward synthetic collagen-model triple-helices. To estimate the importance of cell surface localization and specific structural domains on MT1-MMP proteolysis, activity measurements were performed using a series of membrane-anchored MT1-MMP mutants and compared directly with those of soluble MT1-MMP. MT1-MMP activity (kcat /KM ) on the cell surface was 4.8-fold lower compared with soluble MT1-MMP, with the effect largely manifested in kcat . Deletion of the MT1-MMP cytoplasmic tail enhanced cell surface activity, with both kcat and KM values affected, while deletion of the hemopexin-like domain negatively impacted KM and increased kcat . Overall, cell surface localization of MT1-MMP restricts substrate binding and protein-coupled motions (based on changes in both kcat and KM ) for catalysis. Comparison of soluble and cell surface-bound MT2-MMP revealed 12.9-fold lower activity on the cell surface. The cell-based assay was utilized for small molecule and triple-helical transition state analog MMP inhibitors, which were found to function similarly in solution and at the cell surface. These studies provide the first quantitative assessments of MT1-MMP activity and inhibition in the native cellular environment of the enzyme.
© 2018 John Wiley & Sons A/S.

Entities:  

Keywords:  cell surface proteolysis; cell-based assay; collagenolysis; matrix metalloproteinase; protease inhibitor

Mesh:

Substances:

Year:  2018        PMID: 30480376      PMCID: PMC6536371          DOI: 10.1111/cbdd.13450

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  100 in total

1.  Design and therapeutic application of matrix metalloproteinase inhibitors.

Authors:  M Whittaker; C D Floyd; P Brown; A J Gearing
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

2.  Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis.

Authors:  A Jiang; K Lehti; X Wang; S J Weiss; J Keski-Oja; D Pei
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

Review 3.  Structural properties of matrix metalloproteinases.

Authors:  W Bode; C Fernandez-Catalan; H Tschesche; F Grams; H Nagase; K Maskos
Journal:  Cell Mol Life Sci       Date:  1999-04       Impact factor: 9.261

4.  Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain.

Authors:  K Lehti; H Valtanen; S A Wickström; J Lohi; J Keski-Oja
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

5.  Expression of human membrane type 1 matrix metalloproteinase in Pichia pastoris.

Authors:  M Roderfeld; F H Büttner; E Bartnik; H Tschesche
Journal:  Protein Expr Purif       Date:  2000-08       Impact factor: 1.650

6.  Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.

Authors:  Y Itoh; A Takamura; N Ito; Y Maru; H Sato; N Suenaga; T Aoki; M Seiki
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

7.  Mutation analysis of membrane type-1 matrix metalloproteinase (MT1-MMP). The role of the cytoplasmic tail Cys(574), the active site Glu(240), and furin cleavage motifs in oligomerization, processing, and self-proteolysis of MT1-MMP expressed in breast carcinoma cells.

Authors:  D V Rozanov; E I Deryugina; B I Ratnikov; E Z Monosov; G N Marchenko; J P Quigley; A Y Strongin
Journal:  J Biol Chem       Date:  2001-05-02       Impact factor: 5.157

8.  Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type 1 matrix metalloproteinase.

Authors:  Kaisa Lehti; Jouko Lohi; Minna M Juntunen; Duanqing Pei; Jorma Keski-Oja
Journal:  J Biol Chem       Date:  2002-01-04       Impact factor: 5.157

9.  Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3.

Authors:  K Hotary; E Allen; A Punturieri; I Yana; S J Weiss
Journal:  J Cell Biol       Date:  2000-06-12       Impact factor: 10.539

10.  Cytoplasmic tail-dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity.

Authors:  T Uekita; Y Itoh; I Yana; H Ohno; M Seiki
Journal:  J Cell Biol       Date:  2001-12-24       Impact factor: 10.539

View more
  2 in total

1.  Kallikrein-Related Peptidase 14 Activates Zymogens of Membrane Type Matrix Metalloproteinases (MT-MMPs)-A CleavEx Based Analysis.

Authors:  Katherine Falkowski; Ewa Bielecka; Ida B Thøgersen; Oliwia Bocheńska; Karolina Płaza; Magdalena Kalińska; Laura Sąsiadek; Małgorzata Magoch; Aleksandra Pęcak; Magdalena Wiśniewska; Natalia Gruba; Magdalena Wysocka; Anna Wojtysiak; Magdalena Brzezińska-Bodal; Kamila Sychowska; Anastasija Pejkovska; Maren Rehders; Georgina Butler; Christopher M Overall; Klaudia Brix; Grzegorz Dubin; Adam Lesner; Andrzej Kozik; Jan J Enghild; Jan Potempa; Tomasz Kantyka
Journal:  Int J Mol Sci       Date:  2020-06-19       Impact factor: 5.923

Review 2.  Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression.

Authors:  Stephan Niland; Andrea Ximena Riscanevo; Johannes Andreas Eble
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.